266 A phase II study of VP-16 plus ifosfamide plus cisplatin (VIP) plus concurrent radiation therapy (XRT) for previously untreated limited small cell lung cancer (SCLC): A Hoosier Oncology Group (HOG) trial

Lung Cancer ◽  
1997 ◽  
Vol 18 ◽  
pp. 70
Author(s):  
A.B. Sandler ◽  
R. Ansari ◽  
W. Fisher ◽  
R. Gonin ◽  
R. Levy ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document